Cited by 27Barrier Structure and Function StudiesCerebrovascular and genetic disordersDrug Transport and Resistance Mechanisms

Endothelial-Ercc1 DNA repair deficiency provokes blood-brain barrier dysfunction

Open access
Hansen, Cathrin E., Vacondio, Davide, van der Molen, Lennart, Jüttner, Annika A., Fung, Wing Ka, Karsten, Manon, van het Hof, Bert, Fontijn, Ruud D. +6 more·2025·Cell Death & Disease

Published version of a preprint

Abstract

Aging of the brain vasculature plays a key role in the development of neurovascular and neurodegenerative diseases, thereby contributing to cognitive impairment. Among other factors, DNA damage strongly promotes cellular aging, however, the role of genomic instability in brain endothelial cells (EC) and its potential effect on brain homeostasis is still largely unclear. We here investigated how endothelial aging impacts blood-brain barrier (BBB) function by using excision repair cross complementation group 1 (ERCC1)-deficient human brain ECs and an EC-specific Ercc1 knock out (EC-KO) mouse model. In vitro, ERCC1-deficient brain ECs displayed increased senescence-associated secretory phenotype expression, reduced BBB integrity, and higher sprouting capacities due to an underlying dysregulation of the Dll4-Notch pathway. In line, EC-KO mice showed more P21 + cells, augmented expression of angiogenic markers, and a concomitant increase in the number of brain ECs and pericytes. Moreover, EC-KO mice displayed BBB leakage and enhanced cell adhesion molecule expression accompanied by peripheral immune cell infiltration into the brain. These findings were confined to the white matter, suggesting a regional susceptibility. Collectively, our results underline the role of endothelial aging as a driver of impaired BBB function, endothelial sprouting, and increased immune cell migration into the brain, thereby contributing to impaired brain homeostasis as observed during the aging process.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41419-024-07306-0

Cites

16 of 16 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Dysfunction of SHIP1 has been associated with a spectrum of diseases, including AD, AML, SLE, RA.

    “As such, dysfunction of SHIP1 has been associated with a spectrum of diseases, including Alzheimer’s disease (AD), acute myeloid leukemia (AML) and autoimmune diseases such as systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA)3–6.”

    From INPP5D/SHIP1 regulates endo-lysosomal function and cargo-selective phagocytosis in human microglia (2025) · cites this paper as [6]

    The Results section on ERCC1 deficiency and blood-brain barrier impairment concerns ERCC1, not SHIP1. Searches of our copy for SHIP1, INPP5D, acute myeloid leukemia, lupus, and rheumatoid arthritis found no passage linking SHIP1 dysfunction to the listed diseases. The paper mentions Alzheimer’s disease in another context, without making the claimed SHIP1 association. (LLM, conf=0.77)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 79

  1. [1]Kadry H, Noorani B, Cucullo L. A blood–brain barrier overview on structure, function, impairment, and biomarkers of integrity. Fluids Barriers CNS. 2020;17:69. 33208141 PMC7672931 · DOI · Paper page
  2. [2]Han L, Jiang C. Evolution of blood-brain barrier in brain diseases and related systemic nanoscale brain-targeting drug delivery strategies. Acta Pharm Sin B. 2021;11:2306–25. 34522589 PMC8424230 · DOI · Paper page
  3. [3]Donato AJ, Magerko KA, Lawson BR, Durrant JR, Lesniewski LA, Seals DR. SIRT-1 and vascular endothelial dysfunction with ageing in mice and humans. J Physiol. 2011;589:4545–54. 21746786 PMC3208223 · DOI
  4. [4]Banks WA, Reed MJ, Logsdon AF, Rhea EM, Erickson MA. Healthy aging and the blood–brain barrier. Nat Aging. 2021;1:243–54. 34368785 PMC8340949 · DOI
  5. [5]Tarantini S, Tran CHT, Gordon GR, Ungvari Z, Csiszar A. Impaired neurovascular coupling in aging and Alzheimer’s disease: Contribution of astrocyte dysfunction and endothelial impairment to cognitive decline. Exp Gerontol. 2017;94:52–8. 27845201 PMC5429210 · DOI · Paper page
  6. [6]Fukuhara M, Matsumura K, Ansai T, Takata Y, Sonoki K, Akifusa S, et al. Prediction of cognitive function by arterial stiffness in the very elderly. Circ J. 2006;70:756–61. 16723799 · DOI
  7. [7]Farrall AJ, Wardlaw JM. Blood–brain barrier: Ageing and microvascular disease – systematic review and meta-analysis. Neurobiol Aging. 2009;30:337–52. 17869382 · DOI · Paper page
  8. [9]Ungvari Z, Tarantini S, Kiss T, Wren JD, Giles CB, Griffin CT, et al. Endothelial dysfunction and angiogenesis impairment in the ageing vasculature. Nat Rev Cardiol. 2018;15:555–65. 29795441 PMC6612360 · DOI
  9. [10]Simons M. Angiogenesis. Circulation. 2005;111:1556–66. 15795364 · DOI
  10. [11]Brown WR, Thore CR. Review: cerebral microvascular pathology in ageing and neurodegeneration. Neuropathol Appl Neurobiol. 2011;37:56–74. 20946471 PMC3020267 · DOI · Paper page
  11. [12]Farkas E, de Vos RAI, Donka G, Jansen Steur EN, Mihály A, Luiten PGM. Age-related microvascular degeneration in the human cerebral periventricular white matter. Acta Neuropathol. 2006;111:150–7. 16453142 · DOI
  12. [13]Brown WR, Moody DM, Thore CR, Challa VR, Anstrom JA. Vascular dementia in leukoaraiosis may be a consequence of capillary loss not only in the lesions, but in normal-appearing white matter and cortex as well. J Neurol Sci. 2007;257:62–6. 17320909 PMC1989116 · DOI · Paper page
  13. [14]Georgieva I, Tchekalarova J, Iliev D, Tzoneva R. Endothelial senescence and its impact on angiogenesis in Alzheimer’s disease. Int J Mol Sci. 2023;24:11344. PMC10379128 37511104
  14. [15]Moriya J, Minamino T. Angiogenesis, Cancer, and vascular aging. Front. Cardiovasc Med. 2017;4:65. PMC5660731 29114540
  15. [18]Yousufuddin M, Young N. Aging and ischemic stroke. Aging (Albany NY). 2019;11:2542–4. 31043575 PMC6535078 · DOI
  16. [19]Jefferson AL, Cambronero FE, Liu D, Moore EE, Neal JE, Terry JG, et al. Higher aortic stiffness is related to lower cerebral blood flow and preserved cerebrovascular reactivity in older adults. Circulation. 2018;138:1951–62. 30018169 PMC6394409 · DOI
  17. [20]Mitchell GF, Wang N, Palmisano JN, Larson MG, Hamburg NM, Vita JA, et al. Hemodynamic correlates of blood pressure across the adult age spectrum: noninvasive evaluation in the Framingham Heart Study. Circulation. 2010;122:1379–86. 20855656 PMC2981604 · DOI
  18. [21]Wang F, Cao Y, Ma L, Pei H, Rausch WD, Li H. Dysfunction of cerebrovascular endothelial cells: prelude to vascular dementia. Front Aging Neurosci. 2018;10:376. 30505270 PMC6250852 · DOI
  19. [22]Ogrodnik M. Cellular aging beyond cellular senescence: markers of senescence prior to cell cycle arrest in vitro and in vivo. Aging Cell 2021;20:e13338. 33711211 PMC8045927 · DOI · Paper page
  20. [23]Vermeij WP, Dollé ME, Reiling E, Jaarsma D, Payan-Gomez C, Bombardieri CR, et al. Restricted diet delays accelerated ageing and genomic stress in DNA-repair-deficient mice. Nature. 2016;537:427–31. 27556946 PMC5161687 · DOI · Paper page
  21. [24]Gyenis A, Chang J, Demmers JJPG, Bruens ST, Barnhoorn S, Brandt RMC, et al. Genome-wide RNA polymerase stalling shapes the transcriptome during aging. Nat Genet. 2023;55:268–79. 36658433 PMC9925383 · DOI
  22. [26]Wong A, Kieu T, Robbins PD. The Ercc1(-/Δ) mouse model of accelerated senescence and aging for identification and testing of novel senotherapeutic interventions. Aging (Albany NY). 2020;12:24481–3. 33353886 PMC7803498 · DOI · Paper page
  23. [27]Bautista-Niño PaulaK, Portilla-Fernandez E, Rubio-Beltrán E, van der Linden JanetteJ, de Vries R, van Veghel R, et al. Local endothelial DNA repair deficiency causes aging-resembling endothelial-specific dysfunction. Clin Sci. 2020;134:727–46. 32202295 · DOI
  24. [28]van der Linden J, Stefens SJM, Heredia-Genestar JM, Ridwan Y, Brandt RMC, van Vliet N, et al. Ercc1 DNA repair deficiency results in vascular aging characterized by VSMC phenotype switching, ECM remodeling, and an increased stress response. Aging Cell. 2024;23:e14126. PMC11113264 38451018
  25. [29]Hill RobertA, Tong L, Yuan P, Murikinati S, Gupta S, Grutzendler J. Regional blood flow in the normal and ischemic brain is controlled by arteriolar smooth muscle cell contractility and not by capillary pericytes. Neuron. 2015;87:95–110. 26119027 PMC4487786 · DOI
  26. [31]Reijerkerk A, Lakeman KA, Drexhage JA, van Het Hof B, van Wijck Y, van der Pol SM, et al. Brain endothelial barrier passage by monocytes is controlled by the endothelin system. J Neurochem. 2012;121:730–7. 21777246 · DOI
  27. [33]Hansen CE, Kamermans A, Mol K, Berve K, Rodriguez-Mogeda C, Fung WK, et al. Inflammation-induced TRPV4 channels exacerbate blood–brain barrier dysfunction in multiple sclerosis. J Neuroinflammation. 2024;21:72. 38521959 PMC10960997 · DOI
  28. [35]Leung AW, Murdoch B, Salem AF, Prasad MS, Gomez GA, García-Castro MI. WNT/β-catenin signaling mediates human neural crest induction via a pre-neural border intermediate. Development. 2016;143:398–410. 26839343 PMC4760313 · DOI
  29. [36]Wouters E, de Wit NM, Vanmol J, van der Pol SMA, van Het Hof B, Sommer D, et al. Liver X receptor alpha is important in maintaining blood-brain barrier function. Front Immunol. 2019;10:1811. 31417573 PMC6685401 · DOI
  30. [37]Derada Troletti C, Fontijn RD, Gowing E, Charabati M, van Het Hof B, Didouh I, et al. Inflammation-induced endothelial to mesenchymal transition promotes brain endothelial cell dysfunction and occurs during multiple sclerosis pathophysiology. Cell Death Dis. 2019;10:45. 30718504 PMC6361981 · DOI
  31. [38]Meijering E, Jacob M, Sarria JC, Steiner P, Hirling H, Unser M. Design and validation of a tool for neurite tracing and analysis in fluorescence microscopy images. Cytometry A. 2004;58:167–76. 15057970 · DOI
  32. [39]Lanz MC, Zatulovskiy E, Swaffer MP, Zhang L, Ilerten I, Zhang S, et al. Increasing cell size remodels the proteome and promotes senescence. Mol Cell. 2022;82:3255–69.e8. 35987199 PMC9444988 · DOI
  33. [40]Sharma A, Singh K, Almasan A. Histone H2AX phosphorylation: a marker for DNA damage. Methods Mol Biol. 2012;920:613–26. 22941631 · DOI
  34. [41]Fang JS, Hultgren NW, Hughes CCW. Regulation of partial and reversible endothelial-to-mesenchymal transition in angiogenesis. Front Cell Dev Biol. 2021;9:702021. 34692672 PMC8529039 · DOI
  35. [42]Lobov I, Mikhailova N. The role of Dll4/notch signaling in normal and pathological ocular angiogenesis: Dll4 controls blood vessel sprouting and vessel remodeling in normal and pathological conditions. J Ophthalmol. 2018;2018:3565292. 30116629 PMC6079472 · DOI
  36. [43]Hultgren NW, Fang JS, Ziegler ME, Ramirez RN, Phan DTT, Hatch MMS, et al. Slug regulates the Dll4-Notch-VEGFR2 axis to control endothelial cell activation and angiogenesis. Nat Commun. 2020;11:5400. 33106502 PMC7588439 · DOI
  37. [45]Csiszar A, Ungvari Z, Edwards JG, Kaminski P, Wolin MS, Koller A, et al. Aging-induced phenotypic changes and oxidative stress impair coronary arteriolar function. Circ Res. 2002;90:1159–66. 12065318 · DOI
  38. [46]Asai K, Kudej RK, Shen YT, Yang GP, Takagi G, Kudej AB, et al. Peripheral vascular endothelial dysfunction and apoptosis in old monkeys. Arteriosclerosis Thrombosis Vasc Biol. 2000;20:1493–9. 10845863 · DOI
  39. [47]Cosentino F, Rubattu S, Savoia C, Venturelli V, Pagannonne E, Volpe M. Endothelial dysfunction and stroke. J Cardiovasc Pharmacol. 2001;38:S75–S8. 11811384 · DOI
  40. [48]Kelleher RJ, Soiza RL. Evidence of endothelial dysfunction in the development of Alzheimer’s disease: Is Alzheimer’s a vascular disorder? Am J Cardiovasc Dis. 2013;3:197–226. 24224133 PMC3819581
  41. [49]Tsao CW, Seshadri S, Beiser AS, Westwood AJ, DeCarli C, Au R, et al. Relations of arterial stiffness and endothelial function to brain aging in the community. Neurology. 2013;81:984–91. 23935179 PMC3888200 · DOI
  42. [50]Iadecola C. The pathobiology of vascular dementia. Neuron. 2013;80:844–66. 24267647 PMC3842016 · DOI · Paper page
  43. [51]Wagner KD, Wagner N. The senescence markers p16INK4A, p14ARF/p19ARF, and p21 in organ development and homeostasis. Cells. 2022;11:1966. PMC9221567 35741095
  44. [53]Brauer E, Lange T, Keller D, Görlitz S, Cho S, Keye J, et al. Dissecting the influence of cellular senescence on cell mechanics and extracellular matrix formation in vitro. Aging Cell. 2023;22:e13744. 36514868 PMC10014055 · DOI
  45. [54]de Boer M, Te Lintel Hekkert M, Chang J, van Thiel BS, Martens L, Bos MM, et al. DNA repair in cardiomyocytes is critical for maintaining cardiac function in mice. Aging Cell. 2023;22:e13768. 36756698 PMC10014058 · DOI
  46. [55]Henpita C, Vyas R, Healy CL, Kieu TL, Gurkar AU, Yousefzadeh MJ, et al. Loss of DNA repair mechanisms in cardiac myocytes induce dilated cardiomyopathy. Aging Cell. 2023;22:e13782. 36734200 PMC10086531 · DOI
  47. [56]Watanabe Y, Lee SW, Detmar M, Ajioka I, Dvorak HF. Vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) delays and induces escape from senescence in human dermal microvascular endothelial cells. Oncogene. 1997;14:2025–32. 9160882 · DOI
  48. [57]Lochhead JJ, Yang J, Ronaldson PT, Davis TP. Structure, function, and regulation of the blood-brain barrier tight junction in central nervous system disorders. Front Physiol. 2020;11:914. 32848858 PMC7424030 · DOI · Paper page
  49. [59]Ting KK, Coleman P, Kim HJ, Zhao Y, Mulangala J, Cheng NC, et al. Vascular senescence and leak are features of the early breakdown of the blood-brain barrier in Alzheimer’s disease models. Geroscience. 2023;45:3307–31. 37782439 PMC10643714 · DOI
  50. [63]Pelegrí C, Canudas AM, del Valle J, Casadesus G, Smith MA, Camins A, et al. Increased permeability of blood-brain barrier on the hippocampus of a murine model of senescence. Mech Ageing Dev. 2007;128:522–8. 17697702 · DOI
  51. [64]Verheggen ICM, de Jong JJA, van Boxtel MPJ, Gronenschild E, Palm WM, Postma AA, et al. Increase in blood-brain barrier leakage in healthy, older adults. Geroscience. 2020;42:1183–93. 32601792 PMC7394987 · DOI
  52. [65]Murugesan N, Demarest TG, Madri JA, Pachter JS. Brain regional angiogenic potential at the neurovascular unit during normal aging. Neurobiol Aging. 2012;33:1004.e1–16. 22019053 PMC3266473 · DOI
  53. [66]Bernier LP, Brunner C, Cottarelli A, Balbi M. Location matters: navigating regional heterogeneity of the neurovascular unit. Front Cell Neurosci. 2021;15:696540. 34276312 PMC8277940 · DOI
  54. [67]Hase Y, Horsburgh K, Ihara M, Kalaria RN. White matter degeneration in vascular and other ageing-related dementias. J Neurochem. 2018;144:617–33. 29210074 · DOI
  55. [68]Hahn O, Foltz AG, Atkins M, Kedir B, Moran-Losada P, Guldner IH, et al. Atlas of the aging mouse brain reveals white matter as vulnerable foci. Cell. 2023;186:4117–33.e22. 37591239 PMC10528304 · DOI · Paper page
  56. [69]Johnson NF, Gold BT, Brown CA, Anggelis EF, Bailey AL, Clasey JL, et al. Endothelial function is associated with white matter microstructure and executive function in older adults. Front Aging Neurosci. 2017;9:255. 28824417 PMC5539079 · DOI
  57. [70]Johnson NF, Bahrani AA, Powell DK, Jicha GA, Gold BT. Cardiorespiratory fitness diminishes the effects of age on white matter hyperintensity volume. PLoS ONE 2020;15:e0236986. 32866198 PMC7458283 · DOI
  58. [71]Bahrani AA, Powell DK, Yu G, Johnson ES, Jicha GA, Smith CD. White matter hyperintensity associations with cerebral blood flow in elderly subjects stratified by cerebrovascular risk. J Stroke Cerebrovasc Dis. 2017;26:779–86. 28063772 PMC5473621 · DOI
  59. [73]Li Y, Choi WJ, Wei W, Song S, Zhang Q, Liu J, et al. Aging-associated changes in cerebral vasculature and blood flow as determined by quantitative optical coherence tomography angiography. Neurobiol Aging 2018;70:148–59. 30007164 PMC6119107 · DOI
  60. [74]Cameron DJ, Galvin C, Alkam T, Sidhu H, Ellison J, Luna S, et al. Alzheimer’s-related peptide amyloid-β plays a conserved role in angiogenesis. PLoS ONE 2012;7:e39598. 22792182 PMC3392248 · DOI
  61. [75]Hase Y, Ding R, Harrison G, Hawthorne E, King A, Gettings S, et al. White matter capillaries in vascular and neurodegenerative dementias. Acta Neuropathologica Commun. 2019;7:16. PMC6366070 30732655 · DOI · Paper page
  62. [76]Schager B, Brown CE. Susceptibility to capillary plugging can predict brain region specific vessel loss with aging. J Cereb Blood Flow Metab. 2020;40:2475–90. 31903837 PMC7820682 · DOI
  63. [77]Erdő F, Krajcsi P. Age-related functional and expressional changes in efflux pathways at the blood-brain barrier. Front Aging Neurosci. 2019;11:196. 31417399 PMC6682691 · DOI
  64. [78]Bauer B, Hartz AM, Miller DS. Tumor necrosis factor alpha and endothelin-1 increase P-glycoprotein expression and transport activity at the blood-brain barrier. Mol Pharmacol. 2007;71:667–75. 17132686 · DOI · Paper page
  65. [79]Bauer B, Hartz AMS, Pekcec A, Toellner K, Miller DS, Potschka H. Seizure-induced up-regulation of p-glycoprotein at the blood-brain barrier through glutamate and cyclooxygenase-2 signaling. Mol Pharmacol. 2008;73:1444–53. 18094072 · DOI
  66. [80]Huang L, Chen Y, Liu R, Li B, Fei X, Li X, et al. P-glycoprotein aggravates blood brain barrier dysfunction in experimental ischemic stroke by inhibiting endothelial autophagy. Aging Dis. 2022;13:1546–61. 36186136 PMC9466967 · DOI
  67. [81]Wu B, Ueno M, Onodera M, Kusaka T, Huang C-l, Hosomi N, et al. Age-related changes in P-glycoprotein expression in senescence-accelerated mouse. Curr Aging Sci. 2009;2:187–92. 20021412 · DOI
  68. [82]Erickson MA, Niehoff ML, Farr SA, Morley JE, Dillman LA, Lynch KM, et al. Peripheral administration of antisense oligonucleotides targeting the amyloid-β protein precursor reverses AβPP and LRP-1 overexpression in the aged SAMP8 mouse brain. J Alzheimers Dis. 2012;28:951–60. 22179572 · DOI
  69. [83]Zhang C-l, Wang H-l, Li P-c, Hong C-d, Chen A-q, Qiu Y-m, et al. Mfsd2a overexpression alleviates vascular dysfunction in diabetic retinopathy. Pharmacol Res. 2021;171:105755. 34229049 · DOI
  70. [84]Ben-Zvi A, Lacoste B, Kur E, Andreone BJ, Mayshar Y, Yan H, et al. Mfsd2a is critical for the formation and function of the blood-brain barrier. Nature. 2014;509:507–11. 24828040 PMC4134871 · DOI · Paper page
  71. [85]Spinola M, Falvella FS, Colombo F, Sullivan JP, Shames DS, Girard L, et al. MFSD2A is a novel lung tumor suppressor gene modulating cell cycle and matrix attachment. Mol Cancer. 2010;9:62. 20236515 PMC2846890 · DOI
  72. [86]Reiling JH, Clish CB, Carette JE, Varadarajan M, Brummelkamp TR, Sabatini DM. A haploid genetic screen identifies the major facilitator domain containing 2A (MFSD2A) transporter as a key mediator in the response to tunicamycin. Proc Natl Acad Sci. 2011;108:11756–65. 21677192 PMC3141996 · DOI
  73. [88]Nyúl-Tóth Á, Suciu M, Molnár J, Fazakas C, Haskó J, Herman H, et al. Differences in the molecular structure of the blood-brain barrier in the cerebral cortex and white matter: an in silico, in vitro, and ex vivo study. Am J Physiol-Heart Circulatory Physiol. 2016;310:H1702–H14. 27059078 · DOI
  74. [90]Gorgoulis VG, Pratsinis H, Zacharatos P, Demoliou C, Sigala F, Asimacopoulos PJ, et al. p53-Dependent ICAM-1 overexpression in senescent human cells identified in atherosclerotic lesions. Lab Investig. 2005;85:502–11. 15711569 · DOI · Paper page
  75. [91]Smolders J, Remmerswaal EBM, Schuurman KG, Melief J, van Eden CG, van Lier RAW, et al. Characteristics of differentiated CD8+ and CD4+ T cells present in the human brain. Acta Neuropathol. 2013;126:525–35. 23880787 · DOI
  76. [92]Merlini M, Kirabali T, Kulic L, Nitsch RM, Ferretti MT. Extravascular CD3+ T cells in brains of alzheimer disease patients correlate with tau but not with amyloid pathology: an immunohistochemical study. Neurodegenerative Dis. 2018;18:49–56. 29402847 · DOI
  77. [94]van Olst L, Kamermans A, van der Pol SMA, Rodríguez E, Hulshof LA, van Dijk RE, et al. Age-associated systemic factors change central and peripheral immunity in adult male mice. Brain Behav Immun. 2023;111:395–411. 37169133 · DOI
  78. [95]Zhou L, Kong G, Palmisano I, Cencioni MT, Danzi M, De Virgiliis F, et al. Reversible CD8 T cell-neuron cross-talk causes aging-dependent neuronal regenerative decline. Science. 2022;376:eabd5926. 35549409 · DOI
  79. [96]Hu D, Xia W, Weiner HL. CD8+ T cells in neurodegeneration: friend or foe? Mol Neurodegeneration. 2022;17:59. PMC9437386 36056406 · DOI

Cited by

Sorted by citations

Authors
Hansen, C. E., Vacondio, D., van der Molen, L., Jüttner, A. A., Fung, W. K., Karsten, M., van het Hof, B., Fontijn, R. D., Kooij, G., Witte, M. E., Roks, A. J. M., de Vries, H. E., Mulder, I., & de Wit, N. M.
Affiliations
  • Amsterdam Neuroscience (NL)
  • Erasmus MC (NL)
  • Amsterdam UMC Location Vrije Universiteit Amsterdam (NL)
  • Amsterdam UMC Location University of Amsterdam (NL)
Corresponding author
Hansen, Cathrin E.
Venue
Cell Death & Disease
Published
2025-01-03
Volume
16
Issue
1
Pages
1-1
ISSN
2041-4889 (ISSN-L)
OpenAlex
W4406026710
Cited by
27
References
16
Citations by year
2026: 16 · 2025: 11
FWCI
9.74
Type
journal article
Language
en
Open access
Locations
  • Cell Death and Disease (publishedVersion, cc-by)
  • Research Square (acceptedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • EUR Research Repository (Erasmus University Rotterdam) (publishedVersion, cc-by)
  • Pure Amsterdam UMC (submittedVersion, cc-by)
  • Radboud Repository (Radboud University) (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • European Commission (813294, HORIZON2020, 101097983)
  • ZonMw (10510022110005)
  • Nederlandse Organisatie voor Wetenschappelijk Onderzoek (91719305)
Topics
  • Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
  • Health Sciences › Medicine › Neurology › Cerebrovascular and genetic disorders
  • Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
Keywords
ERCC1, DNA repair deficiency, brain endothelial cells, endothelial aging, blood-brain barrier dysfunction, genomic instability, senescence-associated secretory phenotype, Dll4-Notch signaling, angiogenesis, pericytes, immune cell infiltration, white matter, brain aging, neurodegenerative diseases
MeSH terms
Animals, Blood-Brain Barrier, Brain, DNA Repair, DNA-Binding Proteins, Endonucleases, Humans, Mice, Inbred C57BL, Cellular Senescence, Mice, Knockout, Endothelial Cells, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review